Peel Hunt lowered shares of CONVATEC GRP PL/ADR (OTCMKTS:CNVVY) to a buy rating in a research report sent to investors on Friday, The Fly reports.

Other equities research analysts have also issued reports about the stock. Barclays restated an equal weight rating on shares of CONVATEC GRP PL/ADR in a report on Monday, May 18th. JPMorgan Chase & Co. reissued an underweight rating on shares of CONVATEC GRP PL/ADR in a research note on Wednesday, April 1st. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the stock. CONVATEC GRP PL/ADR has an average rating of Hold.

Shares of CNVVY opened at $10.27 on Friday. CONVATEC GRP PL/ADR has a twelve month low of $6.69 and a twelve month high of $11.28. The firm’s 50 day moving average price is $10.16 and its two-hundred day moving average price is $10.00.


ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.

Further Reading: Why is a lock-up period needed for an IPO?

The Fly

Analyst Recommendations for CONVATEC GRP PL/ADR (OTCMKTS:CNVVY)

Receive News & Ratings for CONVATEC GRP PL/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONVATEC GRP PL/ADR and related companies with's FREE daily email newsletter.